Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GATT-Patch vs TachoSil for Hemostasis in Liver Surgery
NCT05385952Completed
- Sponsor
- GATT Technologies
- Start
- Aug 2022
- Primary completion
- May 2024
- Countries
- 3
01
Overview
Randomised, open-label trial in hemorrhage, sponsored by GATT Technologies. Primary endpoint: Rate of Hemostasis at 3 Minutes Without Rebleeding at the 10-minute Time Point. Started Aug 2022; status: completed.
02
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT05385952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05385952.